COCHEnvoy Medical, Inc.

Nasdaq www.envoymedical.com


$ 3.39 $ 0.21 (6.6 %)    

Thursday, 12-Sep-2024 11:42:09 EDT
QQQ $ 472.19 $ 3.56 (0.76 %)
DIA $ 411.09 $ 1.63 (0.4 %)
SPY $ 557.88 $ 2.89 (0.52 %)
TLT $ 99.72 $ -0.65 (-0.65 %)
GLD $ 235.74 $ 1.10 (0.47 %)
$ 3.18
$ 3.39
-- x --
$ 3.47 x 200
$ 3.39 - $ 3.39
$ 0.75 - $ 11.72
8,355
na
62.33M
$ 0.34
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2024 06-30-2024 10-Q
2 05-15-2024 03-31-2024 10-Q
3 04-01-2024 12-31-2023 10-K
4 11-17-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 04-03-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-31-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-18-2021 06-30-2021 10-Q
14 05-17-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ascendiant-capital-maintains-buy-on-envoy-medical-raises-price-target-to-875

Ascendiant Capital analyst Edward Woo maintains Envoy Medical (NASDAQ:COCH) with a Buy and raises the price target from $8.5...

 envoy-medical-secures-lending-facility-of-10m-of-which-the-company-drew-5m-on-the-facility-at-its-origination

Glen Taylor, Committed Investor and Believer in Envoy Medical's Mission to Help People with Significant Hearing Loss, Provi...

 envoy-medical-q2-eps-027-misses-025-estimate-sales-6800k-miss-8250k-estimate

Envoy Medical (NASDAQ:COCH) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.2...

 ascendiant-capital-initiates-coverage-on-envoy-medical-with-buy-rating-announces-price-target-of-85

Ascendiant Capital analyst Edward Woo initiates coverage on Envoy Medical (NASDAQ:COCH) with a Buy rating and announces Pric...

 envoy-medicals-newly-published-peer-reviewed-article-in-the-current-otorhinolaryngology-reports-highlights-advances-in-fully-implanted-cochlear-implant-technology

Envoy Medical in Position to Leverage its Sensor Technology WHITE BEAR LAKE, MN, June 05, 2024 (GLOBE NEWSWIRE) --  Envoy Medic...

 envoy-medical-q1-2024-gaap-eps-032-sales-5900k-miss-10000k-estimate

Envoy Medical (NASDAQ:COCH) reported quarterly losses of $(0.32) per share. The company reported quarterly sales of $59.00 tho...

 why-ultragenyx-pharmaceutical-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...

 why-byrna-technologies-shares-are-trading-higher-by-around-7-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-ex...

 lake-street-maintains-buy-on-envoy-medical-raises-price-target-to-6

Lake Street analyst Frank Takkinen maintains Envoy Medical (NASDAQ:COCH) with a Buy and raises the price target from $3 to $6.

 envoy-medical-q4-eps-008-beats-020-estimate-sales-9500k-beat-8750k-estimate

Envoy Medical (NASDAQ:COCH) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $(0.20)...

 envoy-medical-fy23-eps-238-down-from-157-yoy-revenue-316k-up-from-237k-yoy

As of December 31, 2023 cash and cash equivalents were approximately $4.2 million.

 envoy-medical-has-received-a-decision-to-grant-european-patent-number-ep3858425-titled-implantable-modular-cochlear-implant-system-with-communication-system-and-network

https://register.epo.org/application?number=EP21163363

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION